Brennan, Jennifer C <br/><br/>
Development of a dual luciferase activity and fluorescamine protein assay adapted to a 384 micro-well plate format: Reducing variability in human luciferase transactivation cell lines aimed at endocrine active substances.  [electronic resource] 

 -  Toxicology in vitro : an international journal published in association with BIBRA  Mar 2018 
 - 18-25 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1879-3177 
<br/><br/><label>Standard No.: </label>10.1016/j.tiv.2017.10.030  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Biological Assay<br/>Breast Neoplasms--chemically induced<br/>Cell Line, Tumor<br/>Cell-Free System--drug effects<br/>Endocrine Disruptors--toxicity<br/>Female<br/>Fluorescamine--analysis<br/>Fluorescent Dyes--analysis<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Genes, Reporter--drug effects<br/>High-Throughput Screening Assays<br/>Hormone Antagonists--pharmacology<br/>Humans<br/>Kinetics<br/>Limit of Detection<br/>Luciferases--genetics<br/>Recombinant Proteins--metabolism<br/>Reproducibility of Results<br/>Transcriptional Activation--drug effects